Answers are grounded in this paper and cite their sources.
Background Glaucoma is characterized by progressive dysfunction of retinal ganglion cells (RGCs) and degeneration of their axons. Although elevated intraocular pressure, mechanical stress, oxidative stress, and inflammation contribute to disease progression, these mechanisms do not fully explain continued neurodegeneration in some patients despite adequate pressure control. RGCs have high energetic demands and depend on mitochondrial metabolism, glycolysis, and metabolic support from glial cells. This review aimed to re-examine glaucoma from the perspective of metabolic flexibility and metabolic reserve and to integrate current evidence into an NAD + /NADH-centered metabolic framework. Methods Relevant mechanistic, preclinical, metabolomic, bioenergetic, and clinical evidence was narratively synthesized, with emphasis on RGC metabolic vulnerability, NAD+ homeostasis, mitochondrial function, lactate/pyruvate metabolism, succinate signaling, ketone utilization, the NMNAT2–SARM1 pathway, and metabolism-targeted interventions. Results Clinical and preclinical studies have reported NAD + insufficiency, mitochondrial dysfunction, altered lactate and succinate metabolism, changes in ketone utilization, and abnormalities in axon-degeneration pathways. However, these findings are often discussed as separate metabolic abnormalities. We propose that they may instead reflect a progressive loss of metabolic adaptation during chronic glaucomatous stress. At an early stage, RGCs may maintain energy homeostasis by adjusting glycolysis, substrate utilization, and mitochondrial metabolism. With persistent stress, metabolic flexibility and mitochondrial reserve may decline, redox homeostasis may become disturbed, and axons may become increasingly vulnerable to NMNAT2-SARM1-associated degeneration. On this basis, we propose a conceptual transition from compensated metabolic stress to metabolic inflexibility and, ultimately, metabolic decompensation. Conclusions Viewing glaucoma through the concepts of metabolic flexibility and metabolic reserve may help integrate currently fragmented metabolic findings into a unified disease process. Future metabolic phenotyping that combines systemic bioenergetic measures, ocular metabolites, functional testing, and structural imaging may help identify distinct forms of metabolic vulnerability and support mechanism-informed precision neuroprotection.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: